Fumaric Acid

Fumaric Acid

SCHEMBL6300513

C[C@@H]1CN[C@@H](C)CN1c1cc(Cl)cc2ccoc12.O=C(O)/C=C/C(=O)O

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.34
XIAP P98170 9/20 0.33
BIRC2 Q13490 9/20 0.33
ATR Q13535 2/20 0.33
ATRIP Q8WXE1 1/20 0.33
HRH2 P25021 1/20 0.32
MCHR1 Q99705 1/20 0.31
PIM1 P11309 1/20 0.31
HDAC1 Q13547 1/20 0.31
MMP2 P08253 1/20 0.30
ADAMTS5 Q9UNA0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL6300516 1.00 HTR6 (0.34) HTR6XIAPBIRC2ATRATRIP
Fumaric Acid SCHEMBL6299557 0.88 MCHR1 (0.33) XIAPATRATRIPMCHR1PIM1
Fumaric Acid SCHEMBL6299618 0.88 MCHR1 (0.33) XIAPATRATRIPMCHR1PIM1
Fumaric Acid SCHEMBL6299615 0.88 MCHR1 (0.33) XIAPATRATRIPMCHR1PIM1
Fumaric Acid SCHEMBL6305695 0.88 MCHR1 (0.33) XIAPATRATRIPMCHR1PIM1
Fumaric Acid SCHEMBL6299553 0.88 MCHR1 (0.33) XIAPATRATRIPMCHR1PIM1
Fumaric Acid SCHEMBL6305697 0.88 MCHR1 (0.33) XIAPATRATRIPMCHR1PIM1
Fumaric Acid SCHEMBL6304470 0.83 HTR2C (0.35)
Fumaric Acid SCHEMBL6299353 0.83 HTR2C (0.35)
Fumaric Acid SCHEMBL6304471 0.83 HTR2C (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6967201-B1 for increasing activation of the 5-HT2C receptor in mammals; treatment of depression, obesity, bulimia, premenstrual syndrome, alcoholism, tobacco abuse, panic disorder ELI LILLY AND COMPANY (US) 2005-11-22 US disclosed
EP-1204654-B1 BENZOFURYLPIPERAZINES: 5-HT2C SEROTONIN RECEPTOR AGONISTS LILLY CO ELI (US) 2003-07-23 EP disclosed